Keywords: آدفوویر; Adefovir; Cocrystal; Syntheses; Structures; Dissolution study
مقالات ISI آدفوویر (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: آدفوویر; Adefovir; Liquid chromatography–tandem mass spectrometry; Solid phase extraction; Pharmacokinetic study
Injectable PLGA Adefovir microspheres; the way for long term therapy of chronic hepatitis-B
Keywords: آدفوویر; Adefovir; Biodegradable microspheres; Poly-lactic-co-glycolic acid; Entrapment efficiency;
Phase IV randomized clinical study: Peginterferon alfa-2a with adefovir or entecavir pre-therapy for HBeAg-positive chronic hepatitis B
Keywords: آدفوویر; Chronic hepatitis B; Hepatitis B e antigen; Peginterferon alfa-2a; Adefovir; Entecavir;
Structural patterns of the human ABCC4/MRP4 exporter in lipid bilayers rationalize clinically observed polymorphisms
Keywords: آدفوویر; 6-MP; 6-mercaptopurine; ABC; ATP-binding cassette; ADV; adefovir; AZT; azidothymidine; BLOSUM; blocks substitution matrix; CFTR; cystic fibrosis transmembrane conductance regulator; Chol; cholesterol; cryo-EM; cryo-electronic microscopy; DMAV; dimethylars
Treatment options in HBV
Keywords: آدفوویر; Hepatitis B; HIV; Liver disease; Interferon; Lamivudine; Adefovir; Treatment;
The development of hepatocarcinoma after long-term antivirus treatment of Chinese patients with chronic hepatitis B virus infection: Incidence, long-term outcomes and predictive factors
Keywords: آدفوویر; HBV; Hepatitis B virus; HCC; Hepatocellular carcinoma; CHB; Chronic hepatitis B; HBsAg; Hepatitis B surface antigen; HBeAg; Hepatitis B e antigen; TB; Total bilirubin; HCV; Hepatitis C virus; HIV; Human immunodeficiency virus; ETV; Entecavir; ADV; Adefovi
Viral minority variants in the core promoter and precore region identified by deep sequencing are associated with response to peginterferon and adefovir in HBeAg negative chronic hepatitis B patients
Keywords: آدفوویر; Peginterferon alfa-2a; Adefovir; Ultra-deep pyrosequencing; Mutation; Hepatitis B e antigen; Response marker; 454 DS; 454 deep sequencing; ALT; alanine aminotransferase; BCP; basal core promoter; cccDNA; covalently closed circular DNA; CHB; chronic hepati
The Ca2+/CaMKK2 axis mediates the telbivudine induced upregulation of creatine kinase: Implications for mechanism of antiviral nucleoside analogs' side effect
Keywords: آدفوویر; LdT; Telbivudine; HBV; hepatitis B virus; CHB; chronic Hepatitis B; CK; creatine kinase; HSKMCs; human skeletal muscle cells; SOD; superoxide dismutase; MDA; malondialdehyde; LPO; lipid peroxide; ROS; reactive oxygen species; CaMKK2; calmodulin-dependent
Apigenin, a novel candidate involving herb-drug interaction (HDI), interacts with organic anion transporter 1 (OAT1)
Keywords: آدفوویر; HDI; herb-drug interaction; OAT1; organic anion transporter 1; TDI; time-dependent inhibition; Apigenin; MDCK-OAT1 cells; TDI; Acyclovir; Adefovir; HDI;
Intrahepatic IP-10 mRNA and plasma IP-10 levels as response marker for HBeAg-positive chronic hepatitis B patients treated with peginterferon and adefovir
Keywords: آدفوویر; HBV; Combination therapy; Peginterferon; Adefovir; Interferon-gamma-inducible protein-10 (IP-10); Intrahepatic IP-10 mRNA expression;
Response-guided peginterferon therapy in patients with HBeAg-positive chronic hepatitis B: A randomized controlled study
Keywords: آدفوویر; ADV; adefovir; AEs; adverse events; ALT; alanine aminotransferase; BMI; body mass index; CHB; chronic hepatitis B; EOF; end of follow-up; EOT; end of treatment; ETV; entecavir; HBV; hepatitis B virus; HBeAg; hepatitis B e antigen; HBeAb; hepatitis B e ant
Antiviral treatment for chronic hepatitis B infection in renal transplant recipients
Keywords: آدفوویر; adefovir; entecavir; hepatitis B virus; lamivudine; renal transplantationADV, adefovir; ALT, alanine transaminase; DNA, deoxynucleic acid; ETV, entecavir; HBeAg, hepatitis B e-antigen; HBsAg, hepatitis B surface antigen; HBV, hepatitis B virus; HIV, human
Clinical Events After Cessation of Lamivudine Therapy in Patients Recovered From Hepatitis B Flare With Hepatic Decompensation
Keywords: آدفوویر; Antiviral Therapy; Cirrhosis; Liver Cancer; Nucleos(t)ide Analog; ADV; adefovir; AFP; alpha fetoprotein; ALT; alanine aminotransferase; anti-HBe; hepatitis B e antibody; cccDNA; covalently closed circular DNA; CHB; chronic hepatitis B; δPT; prolongation
Langmuir monolayers of N-acyl derivatives of adefovir phosphonate at the air/water interface and molecular self-assembly in water
Keywords: آدفوویر; Adefovir; Langmuir monolayer; Lipid derivatives; Molecular self-assembly; Simulation;
Mutations in HBV DNA Polymerase Associated With Nucleos(t)ide Resistance Are Rare in Treatment-naive Patients
Keywords: آدفوویر; CHB; Reverse; Transcriptase; Baseline; ADV; adefovir; ETV; entecavir; HBV; hepatitis B virus; HBeAg; hepatitis B e antigen; LAM; lamivudine; NA; nucleos(t)ide analogue; rt; reverse transcriptase; TDF; tenofovir;
Inhibitory effects of p-aminohippurate and probenecid on the renal clearance of adefovir and benzylpenicillin as probe drugs for organic anion transporter (OAT) 1 and OAT3 in humans
Keywords: آدفوویر; Organic anion transporter (OAT); Probe drug; Renal clearance; Adefovir; Benzylpenicillin
ReviewHepatitis B flares in chronic hepatitis B: Pathogenesis, natural course, and management
Keywords: آدفوویر; ADV; adefovir; AFP; alphafetoprotein; ALT; alanine aminotransferase; anti-CD20; CD20 antibodies; anti-TNF; anti-tumour necrosis factors; ART; antiretroviral therapy; BHN; bridging hepatic necrosis; cccDNA; covalently closed circular DNA; CHB; chronic hepa
Epidemiology and impact of HIV coinfection with Hepatitis B and Hepatitis C viruses in Sub-Saharan Africa
Keywords: آدفوویر; 3TC; Lamivudine; AOR; Adjusted Odds Ratio; ADV; adefovir; ALT; alanine transaminase; Anti-HBcAb; antibody to Hepatitis B core antigen; Anti-HBeAb; antibody to Hepatitis B e-antigen; Chronic hepatitis B; persistence of HBsAg >6months; d4T; Stavudine; ddI;
A Novel Estimation of the Impact of Treatment with Entecavir on Long-Term Mortality, Morbidity, and Health Care Costs of Chronic Hepatitis B in China
Keywords: آدفوویر; adefovir; chronic hepatitis B; cost benefit; entecavir; lamivudine; telbivudine;
Research ArticleSimilar evolution of hepatitis B virus quasispecies in patients with incomplete adefovir response receiving tenofovir/emtricitabine combination or tenofovir monotherapy
Keywords: آدفوویر; HBV; hepatitis B virus; TDF; tenofovir disoproxil fumarate; FTC; emtricitabine; ADV; adefovir; LAM; lamivudine; PCR; reverse transcriptase chain reaction; QS; quasispecies; NA; nucleos(t)ides analogues; VL; viral load; WT; wild type; Hepatitis B virus; An
Study of the ionic equilibriums in aqueous solutions and coordination properties of Adefovir and Cidofovir used as antiviral drugs
Keywords: آدفوویر; Adefovir; Cidofovir; Nucleotide analog; Equilibrium constants; Job's method
Prevalence, virology and antiviral drugs susceptibility of hepatitis B virus rtN238H polymerase mutation from 1865 Chinese patients with chronic hepatitis B
Keywords: آدفوویر; Hepatitis B virus; Lamivudine; Adefovir; Drug resistance; Polymorphism;
Research ArticleBenefits associated with antiviral treatment in kidney allograft recipients with chronic hepatitis B virus infection
Keywords: آدفوویر; HBV; hepatitis B virus; RTR; renal transplanted recipients; KT; kidney transplantation; EPO; erythropoietin; LAM; lamivudine; ADV; adefovir; ETV; entecavir; TDF; tenofovir; FTC; emtricitabine; HCC; hepatocellular carcinoma; Hepatitis B virus; Kidney trans
Comparison of entecavir and adefovir for the treatment of chronic hepatitis B
Keywords: آدفوویر; Entecavir; Adefovir; Hepatitis B
Voltammetric quantification of anti-hepatitis drug Adefovir in biological matrix and pharmaceutical formulation
Keywords: آدفوویر; Voltammetry; Adefovir; Solid-phase extraction; Protein-precipitation; Human plasma; Pharmaceutical formulation
Synthesis, anti-HBV activity and renal cell toxicity evaluation of mixed phosphonate prodrugs of adefovir
Keywords: آدفوویر; Adefovir; Non-steroidal anti-inflammatory drugs; l-Amino (thio)acids; Principle of hybridization; Hepatitis B virus
Milestones in the discovery of antiviral agents: nucleosides and nucleotides
Keywords: آدفوویر; Valacyclovir; Brivudin; FV-100; Emtricitabine; (S)-HPMPA; (S)-HPMPC; Cidofovir; Adefovir; Tenofovir; Truvada®; Phosphonoamidate
Efficacy and tolerance of a combination of tenofovir disoproxil fumarate plus emtricitabine in patients with chronic hepatitis B: A European multicenter study
Keywords: آدفوویر; ADV; adefovir; ALT; alanine aminotransferase; CHB; chronic hepatitis B; ETV; entecavir; FTC; emtricitabine; HBV; hepatitis B virus; HIV; human immunodeficiency virus; TDF; tenofovir; ULN; upper limit of normal; Chronic hepatitis B; Tenofovir; Emtricitabin
Treatment of chronic hepatitis B: Update of the recommendations from the 2007 Italian Workshop
Keywords: آدفوویر; Adefovir; Cirrhosis; Entecavir; HBV; Lamivudine; Telbivudine; Tenofovir
Self-nanoemulsifying drug delivery system for adefovir dipivoxil: Design, characterization, in vitro and ex vivo evaluation
Keywords: آدفوویر; Adefovir; SNEDDS; pH-dependent solubility; Ex vivo drug release
New prodrugs of Adefovir and Cidofovir
Keywords: آدفوویر; Adefovir; Cidofovir; Antivirals; Prodrugs; Acyclic nucleoside phosphonate; Phosphonate ester; In vitro evaluation
Lamivudine and adefovir resistance in children and young adults with chronic hepatitis B
Keywords: آدفوویر; Lamivudine; Adefovir; Resistance; Hepatitis B
Hydrophilic interaction liquid chromatography–tandem mass spectrometry for the determination of adefovir in human plasma and its application to a pharmacokinetic study
Keywords: آدفوویر; Adefovir; HILIC–MS/MS; Human plasma; Pharmacokinetic study
Research ArticleAntiviral effect of entecavir in chronic hepatitis B: Influence of prior exposure to nucleos(t)ide analogues
Keywords: آدفوویر; Entecavir; Hepatitis B; Lamivudine; Adefovir; Antiviral therapy; NA; nucleos(t)ide analogues; HBV; hepatitis B virus; ETV; entecavir; LAM; lamivudine; HBeAg; hepatitis B e antigen; VR; virologic response; HIV; human immunodeficiency virus; HCV; hepatitis
Nucleos(t)ide Analogues Only Induce Temporary Hepatitis B e Antigen Seroconversion in Most Patients With Chronic Hepatitis B
Keywords: آدفوویر; Durability; Antiviral Therapy; Discontinuation; Sustained Response; ADV; adefovir; anti-HBe; antibody against hepatitis B e antigen; anti-HBs; antibody against hepatitis B surface antigen; LAM; lamivudine;
Viral hepatitis and HIV co-infection
Keywords: آدفوویر; Hepatitis B; Hepatitis C; Hepatitis delta; HIV; Co-infection; Liver; Interferon; Ribavirin; Entecavir; Adefovir; Lamivudine; Tenofovir; Antiviral drugs
Partial virological response to nucleos(t)ide analogues in naïve patients with chronic hepatitis B: From guidelines to field practice
Keywords: آدفوویر; HBV; hepatitis B virus; PVR; partial virological responders; NUC; nucleos(t)ide analogues; LMV; lamivudine; LDT; telbivudine; ADV; adefovir; ETV; entecavir; TDF; tenofovir; FTC; emtriÄitabine;
Clinical outcome of lamivudine-resistant chronic hepatitis B patients with compensated cirrhosis under adefovir salvage treatment.: Importance of HCC surveillance
Keywords: آدفوویر; HCC; Lamivudine; Resistance; Adefovir; HBV; Surveillance
Serum HBsAg changes in HBeAg positive chronic hepatitis B patients with continuous viral load reductions during treatment with adefovir or peg-interferon-α-2a
Keywords: آدفوویر; Chronic hepatitis B; Hepatitis B surface antigen; Peg-interferon-α-2a; Adefovir
Sensitivity and accuracy of an updated line probe assay (HBV DR v.3) in detecting mutations associated with hepatitis B antiviral resistance
Keywords: آدفوویر; ADV; adefovir; ETV; entecavir; HBV; hepatitis B virus; INNO-LIPA HBV DR v.3; HBV drug resistance line probe assay version 3; LAM; lamivudine; RFLP; restriction fragment length polymorphism analysis; TDF; tenofovir; Hepatitis B virus; Lamivudine; Adefovir;
Telbivudine, a nucleoside analog inhibitor of HBV polymerase, has a different in vitro cross-resistance profile than the nucleotide analog inhibitors adefovir and tenofovir
Keywords: آدفوویر; Telbivudine; Nucleoside analog; HBV; Adefovir; Tenofovir
The profile of mutational clusters associated with lamivudine resistance can be constrained by HBV genotypes
Keywords: آدفوویر; HBV; hepatitis B virus; RT; reverse transcriptase; Ns(t)RTI; nucleos(t)ide reverse transcriptase inhibitors; LMV; lamivudine; ETV; entecavir; TBV; telbivudine; ADV; adefovir; HBeAg; HBV e antigen; HBsAg; HBV s antigen; FDR; false discovery rate; IQR; inte
Permeation enhancer dodecyl 6-(dimethylamino)hexanoate increases transdermal and topical delivery of adefovir: Influence of pH, ion-pairing and skin species
Keywords: آدفوویر; Adefovir; Acyclic nucleoside phosphonates; Antiviral; Transdermal drug delivery; Permeation enhancer
Hepatitis B virus quasispecies susceptibility to entecavir confirms the relationship between genotypic resistance and patient virologic response
Keywords: آدفوویر; Hepatitis B virus; Entecavir; Baraclude; Resistance; Reverse transcriptase; ETV; entecavir; ETVr; ETV resistance; LVD; lamivudine; LVDr; LVD resistance; ADV; adefovir; ADVr; ADV resistance; LdT; telbivudine; HBV; hepatitis B virus; RT; reverse transcripta
Transdermal and dermal delivery of adefovir: Effects of pH and permeation enhancers
Keywords: آدفوویر; Skin absorption; Transdermal drug delivery; Permeation enhancer; Adefovir; Acyclic nucleoside phosphonates
Low risk of adefovir resistance in lamivudine-resistant chronic hepatitis B patients treated with adefovir plus lamivudine combination therapy: Two-year follow-up
Keywords: آدفوویر; Adefovir dipivoxil; Lamivudine-resistant mutant; Hepatitis B virus; rtA181T; rtN236T; Combination therapy; LAM; lamivudine; ADV; adefovir; rt; reverse transcriptase;
Impact of hepatitis B virus rtA181V/T mutants on hepatitis B treatment failure
Keywords: آدفوویر; HBV; hepatitis B virus; LAM; lamivudine; ADV; adefovir; ETV; entecavir; LdT; telbivudine; YMDD; tyrosine, methionine, aspartate, aspartate; RT; reverse transcriptase; wt; wild-type; TDF; tenofovir; a.a.; amino acid; IC; inhibitory concentration; Pathogene
Nucleos(t)ide analogues for hepatitis B virus: Strategies for long-term success
Keywords: آدفوویر; cirrhosis; drug resistance; hepatitis B virus; hepatocellular carcinoma; nucleos(t)ide analogue; lamivudine; adefovir; entecavir; telbivudine;
Tratamiento farmacológico de la hepatitis B
Keywords: آدفوویر; Hepatitis B; Interferón alfa 2b; Interferón pegilado alfa 2a; Lamivudina; Adefovir; Entecavir; Telbivudina; GuÃas de práctica clÃnica; Hepatitis B; Interferon alpha 2b; Pegylated interferon alpha 2a; Lamivudine; Adefovir; Entecavir; Telbivudine; Clin